Otolith Labs Is A Medical Technology Company Based In Washingtond C Dedicated To Developing Innovative Solutions For Vestibular Disordersparticularly Chronic Vertigothe Company Aims To Enhance The Quality Of Life For Millions Of Americans By Offering A Noninvasive Treatment Option Through Its Patented Technologynon Invasive Vestibular Resonance Therapynvrt This Approach Targets The Vestibular System To Alleviate Vertigo Symptoms Without The Need For Surgery Or Complex Fittings The Company Is Working On A Prescription Wearable Device Designed Specifically For Treating Chronic Vertigothis Compactheadworn Device Aims To Provide Fast Acting Relief From Symptomsotolith Labs Is Also Engaged In Clinical Studies To Validate The Effectiveness Of Its Technologywith Significant Fundingincluding A $20 Million Series A Round Led By Morningside Ventures And Investments From Mark Cubanthe Company Is Advancing Its Clinical Programs And Preparing For Fda Approval And Commercial Launchotolith Labs Has Received An Fda Breakthrough Device Designation And Is Part Of Medtech Innovatoremphasizing Its Commitment To Improving Treatment Options For Those Affected By Vestibular Disorders
No conferences found for this company.
| Company Name | Otolith Labs |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
